Filing Flows › ARS Pharmaceuticals (SPRY) › Recalls, complaints & regulation
ARS Pharmaceuticals (SPRY): clinical trials
ARS Pharmaceuticals (SPRY) beyond its filings: 2 active clinical trials.
ARS Pharmaceuticals' latest quarter
ARS Pharmaceuticals, Q3 2026: revenue $37.7M (+16% year over year), operating margin -90.6%, net loss $35.6M, operating cash flow −$33.7M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does ARS Pharmaceuticals have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.